Personas / Equipo Humano

Jaume Campistol Plana

Buscador de publicaciones

Publicaciones

  • Vidal-Falcó S, Brandi-Tarrau N, Pacheco-Fernández P, Gerotina E, Blasco-Perez L, Trotta JR, Derdak S, O'Callaghan-Gordo M, Garcia-Cazorla A, Pineda M and Armstrong-Moron J.

    The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome.

    SCIENTIFIC REPORTS . 7(1): 12288-12288. Nº de citas: 19

    [doi:10.1038/s41598-017-11620-3]

  • van Spronsen FJ, van Wegberg AM, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol-Plana J, Feillet F, Gizewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, Trefz FK, van Rijn M, Walter JH and MacDonald A.

    Key European guidelines for the diagnosis and management of patients with phenylketonuria.

    LANCET DIABETES & ENDOCRINOLOGY . 5(9): 743-756. Nº de citas: 270

    [doi:10.1016/S2213-8587(16)30320-5]

  • Mendes MI, Smith DE, Pop A, Lennertz P, Ojeda MR, Kanhai WA, van Dooren SJ, Anikster Y, Baric I, Boelen C, Campistol-Plana J, de Boer L, Kariminejad A, Kayserili H, Roubertie A, Verbruggen KT, Vianey-Saban C, Williams M and Salomons GS.

    Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity.

    HUMAN MUTATION . 38(5): 524-531. Nº de citas: 21

    [doi:10.1002/humu.23181]

  • Caprile C, Campistol-Plana J, Puigcerver L, Gutiérrez-Mata AP, Alonso-Colmenero I, Colomé-Roura R and Navarra J.

    Subtle visuomotor deficits and reduced benefit from practice in early treated phenylketonuria

    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY . 39(10): 931-940. Nº de citas: 2

    [doi:10.1080/13803395.2017.1281381]

  • Pérez-López J, Ceberio-Hualde L, García Morillo JS, Grau-Junyent JM, Hermida Ameijeiras Á, López-Rodríguez M, Morales-Conejo M, Nava Mateos JJ, Aldámiz Echevarri Azuara LJ, Campistol-Plana J, Couce ML, García-Silva MT, González Gutiérrez-Solana L and Del Toro M.

    Proceso de transición de la asistencia pediátrica a la adulta en pacientes con errores congénitos del metabolismo. Documento de consenso.

    MEDICINA CLINICA . 147(11): 506-506. Nº de citas: 8

    [doi:10.1016/j.medcli.2016.09.018]

  • Fons-Estupina C and Campistol-Plana J.

    Creatine Defects and Central Nervous System.

    SEMINARS IN PEDIATRIC NEUROLOGY . 23(4): 285-289. Nº de citas: 19

    [doi:10.1016/j.spen.2016.11.003]

  • Campistol-Plana J.

    Epilepsy in Inborn Errors of Metabolism With Therapeutic Options

    SEMINARS IN PEDIATRIC NEUROLOGY . 23(4): 321-331. Nº de citas: 16

    [doi:10.1016/j.spen.2016.11.006]

  • González MJ, Gassió-Subirachs R, Artuch-Iriberri R and Campistol-Plana J.

    Impaired Neurotransmission in Early-treated Phenylketonuria Patients

    SEMINARS IN PEDIATRIC NEUROLOGY . 23(4): 332-340. Nº de citas: 23

    [doi:10.1016/j.spen.2016.11.007]

  • Campistol-Plana J, Díez-Juan M, Callejón L, Fernandez-De Miguel A, Casado-Rio M, Garcia-Cazorla A, Lozano R and Artuch-Iriberri R.

    Inborn error metabolic screening in individuals with nonsyndromic autism spectrum disorders

    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY . 58(8): 842-847. Nº de citas: 28

    [doi:10.1111/dmcn.13114]

  • Yubero-Siles D, Brandi-Tarrau N, Ormazabal-Herrero A, Garcia-Cazorla A, Pérez-Dueñas B, Campistol-Plana J, Ribes A, Palau F, Artuch-Iriberri R, Armstrong-Moron J and Working Group.

    Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism

    PLoS One . 11(5): . Nº de citas: 40

    [doi:10.1371/journal.pone.0156359]